Product Information

FLEQSUVY 25 MG/5 ML SUSPENSION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $5.9352 per ML under NDC 52652600101. Its NADAC has been published 149 times since Aug 23, 2023.

The High Outlier badge above means this manufacturer's average price in the baclofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FLEQSUVY 25 MG/5 ML SUSPENSION

baclofen
$5.9352per ML
High Outlier

Strength

5 mg/mL

NDC

52652600101

Classification

Brand

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

BACLOFEN

Approval Type

New Drug (NDA)

FDA Application

NDA215602

On Market Since

2/7/2022

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price Statistics

The NADAC for FLEQSUVY 25 MG/5 ML SUSPENSION has been published 149 times since Aug 23, 2023, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.9352 per ML
All-time high$5.9352 (Jun 24, 2026)
All-time low$5.7385 (May 22, 2024)
52-week high$5.9352
52-week low$5.7623
Median price$5.7662
Average price$5.7924
Largest weekly change+3.0% (Dec 31, 2025)
Weeks tracked149
Tracking sinceAug 23, 2023

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.4%

3Y

N/A

5Y

N/A

All

+3.3%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FLEQSUVY 25 MG/5 ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for FLEQSUVY 25 MG/5 ML SUSPENSION, manufactured by Azurity Pharmaceuticals Inc., is $5.9352 per ML (NDC 52652600101), effective Jun 24, 2026.

How has the price of FLEQSUVY 25 MG/5 ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for FLEQSUVY 25 MG/5 ML SUSPENSION has risen 3.3%. It has been tracked across 149 weekly CMS publications since Aug 23, 2023.

What are the highest and lowest recorded NADAC prices for FLEQSUVY 25 MG/5 ML SUSPENSION?

Since Aug 23, 2023, the NADAC for FLEQSUVY 25 MG/5 ML SUSPENSION has ranged from a low of $5.7385 (May 22, 2024) to a high of $5.9352 (Jun 24, 2026), with a median of $5.7662 per ML.

Are there cheaper alternatives to FLEQSUVY 25 MG/5 ML SUSPENSION?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BACLOFEN 25 MG/5 ML SUSPENSION, is $3.5265 per ML — about 41% below FLEQSUVY 25 MG/5 ML SUSPENSION.

Who manufactures FLEQSUVY 25 MG/5 ML SUSPENSION?

FLEQSUVY 25 MG/5 ML SUSPENSION (NDC 52652600101) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.